enasidenib

enasidenib
Trade Name Idhifa
Orphan Indication Acute myeloid leukemia
USA Market Approval USA
USA Designation Date 2014-06-12 00:00:00
Sponsor Celgene Corporation;Corporate Woods Bldg 32, Suite 900, 9225 Indian Creek Parkway;Overland Park, Kansas, 66210